Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Lung Cancer

  Free Subscription


06.03.2017

1 Am J Respir Crit Care Med
1 Ann Surg Oncol
7 Ann Thorac Surg
2 Anticancer Res
1 Arch Bronconeumol
3 Arch Pathol Lab Med
2 Cancer Lett
3 Clin Lung Cancer
1 Clin Nucl Med
1 Eur J Cancer
2 Int J Cancer
2 Int J Radiat Oncol Biol Phys
1 J Cancer Res Clin Oncol
1 J Clin Oncol
1 J Nucl Med
1 J Thorac Oncol
6 Lung Cancer
1 Oncologist
5 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Respir Crit Care Med

  1. LIEVENSE LA, Sterman DH, Cornelissen R, Aerts JG, et al
    Checkpoint Blockade in Lung Cancer and Mesothelioma.
    Am J Respir Crit Care Med. 2017 Mar 2. doi: 10.1164/rccm.201608-1755.
    PubMed     Text format     Abstract available


    Ann Surg Oncol

  2. HENNON M, Landreneau RJ
    Role of Segmentectomy in Treatment of Early-Stage Non-Small Cell Lung Cancer.
    Ann Surg Oncol. 2017 Mar 1. doi: 10.1245/s10434-017-5787.
    PubMed     Text format     Abstract available


    Ann Thorac Surg

  3. ROESEL C, Terjung S, Weinreich G, Gauler T, et al
    A Single-Institution Analysis of the Surgical Management of Pulmonary Large Cell Neuroendocrine Carcinomas.
    Ann Thorac Surg. 2016;101:1909-14.
    PubMed     Text format     Abstract available

  4. EMBUN R, Rivas de Andres JJ, Call S, de Olaiz Navarro B, et al
    Causal Model of Survival After Pulmonary Metastasectomy of Colorectal Cancer: A Nationwide Prospective Registry.
    Ann Thorac Surg. 2016;101:1883-90.
    PubMed     Text format     Abstract available

  5. MOON Y, Kim KS, Lee KY, Sung SW, et al
    Clinicopathologic Factors Associated With Occult Lymph Node Metastasis in Patients With Clinically Diagnosed N0 Lung Adenocarcinoma.
    Ann Thorac Surg. 2016;101:1928-35.
    PubMed     Text format     Abstract available

  6. SEDER CW, Wright CD, Chang AC, Han JM, et al
    The Society of Thoracic Surgeons General Thoracic Surgery Database Update on Outcomes and Quality.
    Ann Thorac Surg. 2016;101:1646-54.
    PubMed     Text format     Abstract available

  7. YOTSUKURA M, Kohno M, Asakura K, Kamiyama I, et al
    Ectopic Adrenocorticotropic Hormone-Secreting Bronchial Carcinoid Diagnosed by Balloon-Occluded Pulmonary Arterial Sampling.
    Ann Thorac Surg. 2016;101:1963-5.
    PubMed     Text format     Abstract available

  8. SCOTT GD, Sauer DA, Woolf KM, Sukumar MS, et al
    Presumed Second Focus of Lung Immunoglobulin G4-Related Disease Found to be Adenocarcinoma.
    Ann Thorac Surg. 2016;101:1965-7.
    PubMed     Text format     Abstract available

  9. NAGATA M, Nakayama H, Matsuzaki T, Furumoto H, et al
    Suspected Aerogenous Lung Metastases From Nasopharyngeal Cancer.
    Ann Thorac Surg. 2016;101:e157-9.
    PubMed     Text format     Abstract available


    Anticancer Res

  10. TANDBERG DJ, Holt T, Kelsey CR
    Plasma Metabolites and Risk of Radiation-induced Esophagitis: A Secondary Analysis from a Prospective Study.
    Anticancer Res. 2017;37:719-725.
    PubMed     Text format     Abstract available

  11. LIM YS, Cha W, Park MW, Jeong WJ, et al
    HIF1alpha in Tumorigenesis of Adenoid Cystic Carcinoma.
    Anticancer Res. 2017;37:599-606.
    PubMed     Text format     Abstract available


    Arch Bronconeumol

  12. RUANO-RAVINA A, Fernandez-Villar A, Barros-Dios JM
    Residential Radon and Risk of Lung Cancer in Never-Smokers.
    Arch Bronconeumol. 2017 Feb 22. pii: S0300-2896(17)30012.
    PubMed     Text format    


    Arch Pathol Lab Med

  13. CHURG A, Attanoos R, Borczuk AC, Chirieac LR, et al
    Dataset for Reporting of Malignant Mesothelioma of the Pleura or Peritoneum: Recommendations From the International Collaboration on Cancer Reporting (ICCR).
    Arch Pathol Lab Med. 2016;140:1104-10.
    PubMed     Text format     Abstract available

  14. MILLER RA, Cagle PT, Bernicker EH
    First-Line Immune Therapy-Implications for Pathologists.
    Arch Pathol Lab Med. 2016;140:739-40.
    PubMed     Text format    

  15. ZAKOWSKI MF, Rekhtman N, Auger M, Booth CN, et al
    Morphologic Accuracy in Differentiating Primary Lung Adenocarcinoma From Squamous Cell Carcinoma in Cytology Specimens.
    Arch Pathol Lab Med. 2016;140:1116-20.
    PubMed     Text format     Abstract available


    Cancer Lett

  16. HOU J, Wang T, Xie Q, Deng W, et al
    N-Myc-interacting protein (NMI) negatively regulates epithelial-mesenchymal transition by inhibiting the acetylation of NF-kappaB/p65.
    Cancer Lett. 2016;376:22-33.
    PubMed     Text format     Abstract available

  17. LENG C, Zhang ZG, Chen WX, Luo HP, et al
    An integrin beta4-EGFR unit promotes hepatocellular carcinoma lung metastases by enhancing anchorage independence through activation of FAK-AKT pathway.
    Cancer Lett. 2016;376:188-96.
    PubMed     Text format     Abstract available


    Clin Lung Cancer

  18. HOW J, Mann J, Laczniak AN, Baggstrom MQ, et al
    Pulsatile Erlotinib in EGFR-Positive Non-Small-Cell Lung Cancer Patients With Leptomeningeal and Brain Metastases: Review of the Literature.
    Clin Lung Cancer. 2017 Feb 9. pii: S1525-7304(17)30042.
    PubMed     Text format     Abstract available

  19. SHIRAN I, Heller E, Jessel S, Kamer I, et al
    Non-Small-cell Lung Cancer Patients With Adenocarcinoma Morphology Have a Better Outcome Compared With Patients Diagnosed With Non-Small-cell Lung Cancer Favor Adenocarcinoma.
    Clin Lung Cancer. 2017 Feb 2. pii: S1525-7304(17)30038.
    PubMed     Text format     Abstract available

  20. JACOBS CD, Jafari ME
    Early Results of Lung Cancer Screening and Radiation Dose Assessment by Low-dose CT at a Community Hospital.
    Clin Lung Cancer. 2017 Feb 2. pii: S1525-7304(17)30040.
    PubMed     Text format     Abstract available


    Clin Nucl Med

  21. FU Z, Liu M, Zhang J, Li Z, et al
    Nasal-Tip Metastasis on 18 F-FDG PET/CT Scan in a Patient With Squamous Lung Carcinoma.
    Clin Nucl Med. 2017 Feb 24. doi: 10.1097/RLU.0000000000001597.
    PubMed     Text format     Abstract available


    Eur J Cancer

  22. WALDER D, O'Brien M
    Looking back and to the future: Are we improving 'cure' in non-small cell lung cancer?
    Eur J Cancer. 2017;75:192-194.
    PubMed     Text format     Abstract available


    Int J Cancer

  23. SHIEH JM, Tang YA, Hu FH, Huang WJ, et al
    A histone deacetylase inhibitor enhances expression of genes inhibiting Wnt pathway and augments activity of DNA demethylation reagent against non-small cell lung cancer.
    Int J Cancer. 2017 Feb 24. doi: 10.1002/ijc.30664.
    PubMed     Text format     Abstract available

  24. WEBER M, Yap S, Goldsbury D, Manners D, et al
    Identifying high risk individuals for targeted lung cancer screening: Independent validation of the PLCOM2012 risk prediction tool.
    Int J Cancer. 2017 Mar 1. doi: 10.1002/ijc.30673.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  25. FOGH SE, Deshmukh S, Berk LB, Dueck AC, et al
    A Randomized Phase 2 Trial of Prophylactic Manuka Honey for the Reduction of Chemoradiation Therapy-Induced Esophagitis During the Treatment of Lung Cancer: Results of NRG Oncology RTOG 1012.
    Int J Radiat Oncol Biol Phys. 2017;97:786-796.
    PubMed     Text format     Abstract available

  26. VERMA V, Shostrom VK, Zhen W, Zhang M, et al
    Influence of Fractionation Scheme and Tumor Location on Toxicities After Stereotactic Body Radiation Therapy for Large (>/=5 cm) Non-Small Cell Lung Cancer: A Multi-institutional Analysis.
    Int J Radiat Oncol Biol Phys. 2017;97:778-785.
    PubMed     Text format     Abstract available


    J Cancer Res Clin Oncol

  27. HATA K, Yoshida J, Udagawa H, Hashimoto H, et al
    The difference in Ezrin-pAkt signaling axis between lepidic and papillary predominant invasive adenocarcinomas of the lung.
    J Cancer Res Clin Oncol. 2016;142:1421-30.
    PubMed     Text format     Abstract available


    J Clin Oncol

  28. SECKL MJ, Ottensmeier CH, Cullen M, Schmid P, et al
    Multicenter, Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Pravastatin Added to First-Line Standard Chemotherapy in Small-Cell Lung Cancer (LUNGSTAR).
    J Clin Oncol. 2017 Feb 27:JCO2016697391. doi: 10.1200/JCO.2016.69.7391.
    PubMed     Text format     Abstract available


    J Nucl Med

  29. SCHWARTZ J, Grkovski M, Rimner A, Schoder H, et al
    Pharmacokinetic Analysis of Dynamic 18F-FMISO PET Data in Non-small Cell Lung Cancer.
    J Nucl Med. 2017 Feb 23. pii: jnumed.116.180422. doi: 10.2967/jnumed.116.180422.
    PubMed     Text format     Abstract available


    J Thorac Oncol

  30. IWAMA E, Goto Y, Murakami H, Harada T, et al
    Alectinib for patients with ALK rearrangement-positive non-small cell lung cancer and a poor performance status (Lung Oncology Group in Kyushu 1401).
    J Thorac Oncol. 2017 Feb 23. pii: S1556-0864(17)30123.
    PubMed     Text format     Abstract available


    Lung Cancer

  31. GACHECHILADZE M, Skarda J, Kolek V, Grygarkova I, et al
    Prognostic and predictive value of loss of nuclear RAD51 immunoreactivity in resected non-small cell lung cancer patients.
    Lung Cancer. 2017;105:31-38.
    PubMed     Text format     Abstract available

  32. SALGIA R, Stille JR, Weaver RW, McCleod M, et al
    A randomized phase II study of LY2510924 and carboplatin/etoposide versus carboplatin/etoposide in extensive-disease small cell lung cancer.
    Lung Cancer. 2017;105:7-13.
    PubMed     Text format     Abstract available

  33. VERONESI G, Colombo P, Novellis P, Crepaldi A, et al
    Pilot study on use of home telephoning to identify and recruit high-risk individuals for lung cancer screening.
    Lung Cancer. 2017;105:39-41.
    PubMed     Text format     Abstract available

  34. YONESAKA K, Hirotani K, von Pawel J, Dediu M, et al
    Circulating heregulin level is associated with the efficacy of patritumab combined with erlotinib in patients with non-small cell lung cancer.
    Lung Cancer. 2017;105:1-6.
    PubMed     Text format     Abstract available

  35. SOO RA, Kim HR, Asuncion BR, Fazreen Z, et al
    Significance of immune checkpoint proteins in EGFR-mutant non-small cell lung cancer.
    Lung Cancer. 2017;105:17-22.
    PubMed     Text format     Abstract available

  36. KATAKAMI N, Hida T, Nokihara H, Imamura F, et al
    Phase I/II study of tecemotide as immunotherapy in Japanese patients with unresectable stage III non-small cell lung cancer.
    Lung Cancer. 2017;105:23-30.
    PubMed     Text format     Abstract available


    Oncologist

  37. ROTH JA, Goulart BH, Ravelo A, Kolkey H, et al
    Survival Gains from First-Line Systemic Therapy in Metastatic Non-Small Cell Lung Cancer in the U.S., 1990-2015: Progress and Opportunities.
    Oncologist. 2017 Feb 27. pii: theoncologist.2016-0253.
    PubMed     Text format     Abstract available


    PLoS One

  38. YIN J, Zhao J, Hu W, Yang G, et al
    Disturbance of the let-7/LIN28 double-negative feedback loop is associated with radio- and chemo-resistance in non-small cell lung cancer.
    PLoS One. 2017;12:e0172787.
    PubMed     Text format     Abstract available

  39. SHIN DW, Kim YI, Kim SJ, Kim JS, et al
    Lung cancer specialist physicians' attitudes towards e-cigarettes: A nationwide survey.
    PLoS One. 2017;12:e0172568.
    PubMed     Text format     Abstract available

  40. HORIBE R, Hirohashi Y, Asano T, Mariya T, et al
    Brother of the regulator of the imprinted site (BORIS) variant subfamily 6 is a novel target of lung cancer stem-like cell immunotherapy.
    PLoS One. 2017;12:e0171460.
    PubMed     Text format     Abstract available

  41. HOU PF, Zhu LJ, Chen XY, Qiu ZQ, et al
    Age-related changes in CD4+CD25+FOXP3+ regulatory T cells and their relationship with lung cancer.
    PLoS One. 2017;12:e0173048.
    PubMed     Text format     Abstract available

  42. SHEN G, Lan Y, Zhang K, Ren P, et al
    Comparison of 18F-FDG PET/CT and DWI for detection of mediastinal nodal metastasis in non-small cell lung cancer: A meta-analysis.
    PLoS One. 2017;12:e0173104.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A


  43. Correction for Shrivastava et al., Global long-range transport and lung cancer risk from polycyclic aromatic hydrocarbons shielded by coatings of organic aerosol.
    Proc Natl Acad Sci U S A. 2017 Feb 27. pii: 201702221.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: